Malignant Pleural Mesothelioma Upcoming Therapies

View All

Malignant Pleural Mesothelioma
Malignant Pleural Mesothelioma Upcoming Therapies

The Malignant Pleural Mesothelioma Market includes several immunotherapy agents, in the pipeline including Keytruda, Opdivo and Yervoy, which have shown promising anticancer activity against mesothelioma in recent clinical trials. These drugs have been approved for other indications and now are being used in mono...

Find More